These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22554769)

  • 41. Effects of L-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responsiveness of sensitized BP2 mice.
    Al Qadi-Nassar B; Bichon-Laurent F; Portet K; Tramini P; Arnoux B; Michel A
    Fundam Clin Pharmacol; 2007 Dec; 21(6):611-20. PubMed ID: 18034662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liriopis tuber inhibit OVA-induced airway inflammation and bronchial hyperresponsiveness in murine model of asthma.
    Lee YC; Lee JC; Seo YB; Kook YB
    J Ethnopharmacol; 2005 Oct; 101(1-3):144-52. PubMed ID: 15982838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effects of cryptoporus polysaccharide on airway constriction, eosinophil release, and chemotaxis in guinea pigs.
    Zhao XY; Xie QM; Chen JQ; Ke CK
    Acta Pharmacol Sin; 2004 Apr; 25(4):503-7. PubMed ID: 15066221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Oryza sativa extract on the progression of airway inflammation and remodeling in an experimental animal model of asthma.
    Lee SH; Choi SM; Sohn YS; Kang KK; Yoo M
    Planta Med; 2006 Apr; 72(5):405-10. PubMed ID: 16557453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma.
    Lee YC; Kim SH; Seo YB; Roh SS; Lee JC
    Int Immunopharmacol; 2006 Apr; 6(4):703-13. PubMed ID: 16504935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intranasal curcumin and its evaluation in murine model of asthma.
    Subhashini ; Chauhan PS; Kumari S; Kumar JP; Chawla R; Dash D; Singh M; Singh R
    Int Immunopharmacol; 2013 Nov; 17(3):733-43. PubMed ID: 24021755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration.
    Moretto N; Caruso P; Bosco R; Marchini G; Pastore F; Armani E; Amari G; Rizzi A; Ghidini E; De Fanti R; Capaldi C; Carzaniga L; Hirsch E; Buccellati C; Sala A; Carnini C; Patacchini R; Delcanale M; Civelli M; Villetti G; Facchinetti F
    J Pharmacol Exp Ther; 2015 Mar; 352(3):559-67. PubMed ID: 25576075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phytochemical profiles and biological activity evaluation of Zanthoxylum bungeanum Maxim seed against asthma in murine models.
    Tang W; Xie Q; Guan J; Jin S; Zhao Y
    J Ethnopharmacol; 2014 Mar; 152(3):444-50. PubMed ID: 24495470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of selective phosphodiesterase inhibitors in comparison with other anti-asthma drugs on allergen-induced eosinophilia in guinea-pig airways.
    Banner KH; Marchini F; Buschi A; Moriggi E; Semeraro C; Page CP
    Pulm Pharmacol; 1995 Feb; 8(1):37-42. PubMed ID: 8535097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PDE inhibitors currently in early clinical trials for the treatment of asthma.
    Matera MG; Page C; Cazzola M
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1267-75. PubMed ID: 24865624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation.
    Kobayashi M; Kubo S; Shiraki K; Iwata M; Hirano Y; Ohtsu Y; Takahashi K; Shimizu Y
    Pharmacology; 2012; 90(3-4):223-32. PubMed ID: 23038661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppressive effects of 3-O-methylquercetin on ovalbumin-induced airway hyperresponsiveness.
    Ko WC; Shih CM; Chen MC; Lai YH; Chen JH; Chen CM; Lin CN
    Planta Med; 2004 Dec; 70(12):1123-7. PubMed ID: 15643544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors.
    Nunes IK; de Souza ET; Cardozo SV; Carvalho VF; Romeiro NC; Silva PM; Martins MA; Barreiro EJ; Lima LM
    PLoS One; 2016; 11(10):e0162895. PubMed ID: 27695125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration--in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic window.
    Villetti G; Carnini C; Battipaglia L; Preynat L; Bolzoni PT; Bassani F; Caruso P; Bergamaschi M; Pisano AR; Puviani V; Stellari FF; Cenacchi V; Volta R; Bertacche V; Mileo V; Bagnacani V; Moretti E; Puccini P; Catinella S; Facchinetti F; Sala A; Civelli M
    J Pharmacol Exp Ther; 2015 Mar; 352(3):568-78. PubMed ID: 25576073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological Profile of GPD-1116, an Inhibitor of Phosphodiesterase 4.
    Nose T; Kondo M; Shimizu M; Hamura H; Yamaguchi Y; Sekine T; Ishitani K
    Biol Pharm Bull; 2016; 39(5):689-98. PubMed ID: 27150141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of a novel series of α-terpineol derivatives as promising anti-asthmatic agents: Their design, synthesis, and biological evaluation.
    Zhu W; Liu X; Wang Y; Tong Y; Hu Y
    Eur J Med Chem; 2018 Jan; 143():419-425. PubMed ID: 29202404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.
    Armani E; Amari G; Rizzi A; De Fanti R; Ghidini E; Capaldi C; Carzaniga L; Caruso P; Guala M; Peretto I; La Porta E; Bolzoni PT; Facchinetti F; Carnini C; Moretto N; Patacchini R; Bassani F; Cenacchi V; Volta R; Amadei F; Capacchi S; Delcanale M; Puccini P; Catinella S; Civelli M; Villetti G
    J Med Chem; 2014 Feb; 57(3):793-816. PubMed ID: 24400806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implication of novel thiazolo-thiophene derivative (MCD-KV-10) for management of asthma.
    Patil D; Dash RP; Thakur SK; Pandya AN; Venkatesh P; Vasu KK; Nivsarkar M
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):229-39. PubMed ID: 24939098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo effective dibenzo[b,d]furan-1-yl-thiazoles as novel PDE-4 inhibitors.
    Balasubramanian G; Narayanan S; Andiappan L; Sappanimuthu T; Thirunavukkarasu S; Sundaram S; Natarajan S; Sivaraman N; Rajagopal S; Nazumudeen FAA; Saxena S; Vishwakarma SL; Narayanan S; Sharma GVR; Srinivasan CV; Kilambi N
    Bioorg Med Chem; 2016 Nov; 24(22):5702-5716. PubMed ID: 27713015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents.
    Wójcik-Pszczoła K; Jankowska A; Ślusarczyk M; Jakieła B; Plutecka H; Pociecha K; Świerczek A; Popiół J; Koczurkiewicz-Adamczyk P; Wyska E; Pękala E; Gosens R; Chłoń-Rzepa G
    Bioorg Chem; 2021 Dec; 117():105409. PubMed ID: 34749117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.